China Usa France Australia state Minnesota covid-19 president China Usa France Australia state Minnesota

Covid-19: US Researchers trial Chloroquine; ASHP reports shortages

Reading now: 896
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Researchers at the University of Minnesota in the US have initiated a clinical trial to asses anti-malaria drug, hydroxychloroquine, a generic and derivative of chloroquine, to fight Covid-19.

According to Reuters, the medication is also being assessed in China, Australia and France. Last month, China National Center for Biotechnology Development reported that chloroquine phosphate demonstrated ‘certain curative effect’ with ‘fairly good efficacy’ in clinical studies.

Hydroxychloroquine is said to have a direct antiviral effect, as well as suppresses the generation of proteins linked to the inflammatory complications of various viral diseases.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA